Essential medicines concept and health technology assessment approaches to prioritising medicines: selection versus incorporation.
作者信息
Brhlikova Petra, Deivanayagam Thilagawathi Abi, Babar Zaheer-Ud-Din, Osorio-de-Castro Claudia Garcia Serpa, Caetano Rosângela, Pollock Allyson M
机构信息
Population Health Sciences Institute, Newcastle University, Baddiley-Clark Bldg, Newcastle Upon Tyne, NE2 4AX, UK.
Lancaster Medical School, Faculty of Health and Medicine, Lancaster University, Lancaster, UK.
出版信息
J Pharm Policy Pract. 2023 Jul 13;16(1):88. doi: 10.1186/s40545-023-00595-4.
Abstract
摘要
相似文献
1
Essential medicines concept and health technology assessment approaches to prioritising medicines: selection versus incorporation.基本药物概念与药物优先排序的卫生技术评估方法：选择与纳入
J Pharm Policy Pract. 2023 Jul 13;16(1):88. doi: 10.1186/s40545-023-00595-4.
2
[Essential medicines and the selection process in management practices of pharmaceutical services in Brazilian states and municipalities].[巴西各州和各市药品服务管理实践中的基本药物及遴选程序]
Cien Saude Colet. 2014 Sep;19(9):3859-68. doi: 10.1590/1413-81232014199.12162013.
3
Essential medicines list in national cancer control plans: a secondary analysis from a global study.国家癌症控制计划中的基本药物清单：一项全球研究的二次分析
Lancet Oncol. 2022 Mar;23(3):e144-154. doi: 10.1016/S1470-2045(21)00706-3.
4
Accessibility and use of essential medicines in health care: Current progress and challenges in India.医疗保健中基本药物的可及性与使用：印度的当前进展与挑战
J Pharmacol Pharmacother. 2013 Jan;4(1):13-8. doi: 10.4103/0976-500X.107642.
5
Prioritising systemic cancer therapies applying ESMO's tools and other resources to assist in improving cancer care globally: the Kazakh experience.利用 ESMO 的工具和其他资源优先考虑系统癌症治疗，以协助改善全球癌症护理：哈萨克斯坦的经验。
ESMO Open. 2022 Feb;7(1):100362. doi: 10.1016/j.esmoop.2021.100362. Epub 2022 Jan 31.
6
Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries.利用健康技术评估来评估新药的价值：在八个欧洲国家进行的系统评价和专家咨询的结果。
Eur J Health Econ. 2018 Jan;19(1):123-152. doi: 10.1007/s10198-017-0871-0. Epub 2017 Mar 16.
7
The "Square Box": Therapeutic Equivalence as a Foundation of the WHO Model List of Essential Medicines.“方盒”：治疗等效性作为世界卫生组织基本药物示范目录的基础
Front Pharmacol. 2020 Sep 11;11:578000. doi: 10.3389/fphar.2020.578000. eCollection 2020.
8
Essential Medicines: An Indian Perspective.基本药物：印度视角
Indian J Community Med. 2015 Oct-Dec;40(4):223-32. doi: 10.4103/0970-0218.164382.
9
Essential Medicines in a High Income Country: Essential to Whom?高收入国家的基本药物：对谁至关重要？
PLoS One. 2015 Dec 9;10(12):e0143654. doi: 10.1371/journal.pone.0143654. eCollection 2015.
10
Where National Medicines Policies Have Taken Us With Patient Involvement and Health Technology Assessment in Africa.非洲国家药品政策在患者参与和卫生技术评估方面的进展
Front Med Technol. 2022 Feb 24;4:810456. doi: 10.3389/fmedt.2022.810456. eCollection 2022.
引用本文的文献
1
Economic assessment of potential changes to essential medicines for diabetes in Uganda.乌干达糖尿病基本药物潜在变化的经济评估。
PLoS One. 2025 Jun 25;20(6):e0326806. doi: 10.1371/journal.pone.0326806. eCollection 2025.
2
The Potential Role of Ecotoxicological Data in National Essential Medicine Lists: A Cross-Sectional Analysis.生态毒理学数据在国家基本药物清单中的潜在作用：一项横断面分析。
Int J Environ Res Public Health. 2025 Apr 17;22(4):632. doi: 10.3390/ijerph22040632.
3
The Political Economy of the World Health Organization Model Lists of Essential Medicines.世界卫生组织基本药物示范清单的政治经济学
Milbank Q. 2025 Mar;103(1):52-99. doi: 10.1111/1468-0009.70001. Epub 2025 Feb 27.
4
[The role of regulatory agencies within health systems during emergencies in BrazilPapel de los organismos regulatorios en los sistemas de salud en situaciones de emergencia en Brasil].[巴西紧急情况下卫生系统中监管机构的作用]
Rev Panam Salud Publica. 2024 Dec 18;48:e130. doi: 10.26633/RPSP.2024.130. eCollection 2024.
5
[Concordance between essential medicines lists and diabetes guidelines in Latin America and the CaribbeanConcordância entre as listas de medicamentos essenciais e diretrizes para diabetes na América Latina e no Caribe].[拉丁美洲和加勒比地区基本药物清单与糖尿病指南之间的一致性]
Rev Panam Salud Publica. 2024 Feb 12;48:e3. doi: 10.26633/RPSP.2024.3. eCollection 2024.
本文引用的文献
1
Registration of essential medicines in Kenya, Tanzania and Uganda: a retrospective analysis.肯尼亚、坦桑尼亚和乌干达的基本药物注册：回顾性分析。
J R Soc Med. 2023 Oct;116(10):331-342. doi: 10.1177/01410768231181263. Epub 2023 Jun 21.
2
Strengthening health technology assessment systems in the global south: a comparative analysis of the HTA journeys of China, India and South Africa.加强全球南方国家的卫生技术评估系统：中国、印度和南非卫生技术评估历程的比较分析
Glob Health Action. 2018;11(1):1527556. doi: 10.1080/16549716.2018.1527556.
3
Challenges to decision-making processes in the national HTA agency in Brazil: operational procedures, evidence use and recommendations.巴西国家 HTA 机构决策过程面临的挑战：操作程序、证据使用和建议。
Health Res Policy Syst. 2018 May 11;16(1):40. doi: 10.1186/s12961-018-0319-8.
4
Policy Change and the National Essential Medicines List Development Process in Brazil between 2000 and 2014: Has the Essential Medicine Concept been Abandoned?政策变化与 2000 至 2014 年期间巴西国家基本药物目录的发展进程：基本药物理念是否被抛弃？
Basic Clin Pharmacol Toxicol. 2018 Apr;122(4):402-412. doi: 10.1111/bcpt.12932. Epub 2017 Dec 4.
5
HEALTH TECHNOLOGY PERFORMANCE ASSESSMENT: REAL-WORLD EVIDENCE FOR PUBLIC HEALTHCARE SUSTAINABILITY.卫生技术绩效评估：公共医疗可持续性的真实世界证据。
Int J Technol Assess Health Care. 2017 Jan;33(2):279-287. doi: 10.1017/S0266462317000423. Epub 2017 Jun 23.
6
Essential medicines for universal health coverage.全民健康覆盖的基本药物。
Lancet. 2017 Jan 28;389(10067):403-476. doi: 10.1016/S0140-6736(16)31599-9. Epub 2016 Nov 8.
7
Are we moving towards a new definition of essential medicines?我们是否正在朝着基本药物的新定义迈进？
J Pharmacol Pharmacother. 2015 Oct-Dec;6(4):233. doi: 10.4103/0976-500X.171874.
8
Guide to clinical practice guidelines: the current state of play.临床实践指南指南：当前的进展情况。
Int J Qual Health Care. 2016 Feb;28(1):122-8. doi: 10.1093/intqhc/mzv115. Epub 2016 Jan 20.
9
Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review.药品的撤资与基于价值的采购策略：一项国际综述。
Pharmacoeconomics. 2015 Sep;33(9):905-24. doi: 10.1007/s40273-015-0293-8.
10
A systematic review of health technology assessment tools in sub-Saharan Africa: methodological issues and implications.撒哈拉以南非洲地区卫生技术评估工具的系统评价：方法学问题与启示
Health Res Policy Syst. 2014 Dec 2;12:66. doi: 10.1186/1478-4505-12-66.
Zotero 插件